Abcellera Biologics

-$0.16 (-1.96%) As of 1:40 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABCL and other ETFs, options, and stocks.

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.

CEO
Carl Lars G. Hansen
Employees
—
Headquarters
Vancouver, British Columbia
Founded
2012

ABCL Key Statistics

Market cap
2.46B
Price-Earnings ratio
14.03
Dividend yield
—
Average volume
3.20M
High today
$8.08
Low today
$7.90
Open price
$7.92
Volume
75.69K
52 Week high
$34.00
52 Week low
$5.42

ABCL News

Simply Wall St3h

Insider Buying: The AbCellera Biologics Inc. CEO, President & Chairperson Just Bought 2.6% More Shares - Simply Wall St

AbCellera Biologics Inc. ( ) shareholders (or potential shareholders) will be happy to see that the CEO, President & Chairperson, Carl Hansen, recently bought a

ABCL Earnings

-$0.08
$0.15
$0.38
$0.61
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
$0.33 per share
Actual
$0.54 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure